Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05625321 · ClinicalTrials.gov registry record · NA

Stepping Into Lifestyle Changes

A NA study of PreDiabetes and Overweight and Obesity, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
273
Enrollment target
2
Study locations

NCT05625321: Active NA study of PreDiabetes and Overweight and Obesity, sponsored by University of Alabama at Birmingham.

NCT05625321 is a NA study of PreDiabetes and Overweight and Obesity that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 273 participants, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (61% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05625321, a NA study of PreDiabetes and Overweight and Obesity, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
273 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to promote healthy weight loss among African American women, age 30 or older, who are pre-diabetic and/or have high blood pressure and who live, work, or worship in select rural communities throughout Alabama and Mississippi. The goal of the study is to help reduce the burden of obesity, diabetes, and high blood pressure for these women and to collect information on the reach, effectiveness, adoption, implementation, maintenance, and cost effectiveness of our two evidence-base weight loss programs.

Primary Outcome

Changes in Weight, measured in pounds

Interventions

  • BEHAVIORAL Educational Group Weight Loss Classes
  • BEHAVIORAL Home Gardening Intervention

Study Locations (2)

Alabama

  • The University of Alabama at Birmingham - Birmingham

Mississippi

  • The University of Mississippi Medical Center - Jackson

Trial Details

FieldValue
Enrollment Target 273 participants
Start Date 2023-03-27
Est. Completion 2026-06-30
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the registry record for NCT05625321 still lists

NCT05625321 is an interventional study that assigns participants to a tested intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (61% lower).

The record links to 3 conditions, with PreDiabetes appearing as the primary indexed condition, and to 2 interventions - of which Educational Group Weight Loss Classes is the first listed.

NCT05625321 reports a single indexed study location in Alabama, Mississippi.

Frequently Asked Questions

What is clinical trial NCT05625321 about?

NCT05625321 is a clinical study titled "Stepping Into Lifestyle Changes". The purpose of this study is to promote healthy weight loss among African American women, age 30 or older, who are pre-diabetic and/or have high blood pressure and who live, work, or worship in select rural communities throughout Alabama and Mississippi. The goal of the study is to help reduce the b...

What is the current status of trial NCT05625321?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 273 participants. The study started on 2023-03-27. Estimated completion is 2026-06-30.

What conditions does trial NCT05625321 study?

This clinical trial studies the following conditions: PreDiabetes, Overweight and Obesity, High Blood Pressure.

What interventions are being tested in trial NCT05625321?

The interventions under investigation include: Educational Group Weight Loss Classes (BEHAVIORAL), Home Gardening Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05625321?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05625321 being conducted?

This trial has 2 study locations across Alabama, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05625321's enrollment target sits among peer trials

273 32nd of 149 higher than 118 of 149 other PreDiabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07229430 · 273 participants · NA

    Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue

  • NCT03808922 · 274 participants · Phase 3

    Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

  • NCT04573504 · 274 participants · Phase 4

    Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair

  • NCT05289557 · 274 participants · Phase 3

    The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05625321, the US trial registry maintained by the National Library of Medicine. NCT05625321 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.